Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients.

نویسندگان

  • Javier Ganame
  • Piet Claus
  • Anne Uyttebroeck
  • Marleen Renard
  • Jan D'hooge
  • Bart Bijnens
  • George R Sutherland
  • Bénédicte Eyskens
  • Luc Mertens
چکیده

BACKGROUND The occurrence of chronic anthracycline cardiotoxicity leading to heart failure and even death is a major concern in the treatment of childhood malignancies. Currently, most treatment protocols use reduced anthracycline doses compared with historical exposure. The long-term effect of these reduced doses on myocardial function has not been well studied. METHODS We examined 56 asymptomatic patients. They all had been treated with anthracyclines at a cumulative dose less than 300 mg/m2 5.2 (range: 2.0-15.2) years before the current evaluation. In all patients, standard two-dimensional, Doppler echocardiographic measurements, end-systolic wall stress calculation, and color Doppler myocardial imaging data were obtained. From the color Doppler myocardial imaging data, peak systolic myocardial velocities, peak systolic strain rate, and peak systolic strain [symbol: see text] were computed. The myocardial acceleration during isovolumetric contraction was measured at the basal left ventricular (LV) lateral and right ventricular free wall. Data were compared with 32 age-matched normal controls. RESULTS In asymptomatic patients previously exposed to low-dose anthracycline treatment, several changes in cardiac function were noted: 1. LV diastolic function was abnormal with a prolonged isovolumetric relaxation time and abnormal pulmonary venous flow patterns. 2. End-systolic wall stress was increased. 3. LV annular motion was reduced. 4. Systolic myocardial deformation was reduced with a significant decrease in both radial and longitudinal peak systolic strain rate and [symbol: see text]. CONCLUSIONS Changes in systolic and diastolic function are noted in asymptomatic patients with normal ejection fraction late after low-dose anthracycline treatment. This confirms that subclinical LV dysfunction is present in patients after low-dose anthracycline treatment during childhood. The long-term significance of these findings warrants further follow-up.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Evaluation of Anthracycline Effects on NT-ProBNP Plasma Level in Children with Malignancy

Background: NT-proBNP is a marker that is released from ventricles in response to pressure and volume overload. Raised plasma level of NT-proBNP is seen in ventricular dysfunction, ventricular muscular mass reduction or ventricular ischemia. Anthracyclines are widely used in treatment of pediatric cancer but their use is associated with cardiotoxicity which increases mortality and morbidity. We...

متن کامل

Effect of myocardial dysfunction in cardiac morbidity and all cause mortality in childhood cancer subjects treated with anthracycline therapy

Background: Subacute cardiotoxicity, consisting of acute myocyte damage and associated left ventricular dysfunction, occurs early during anthracycline therapy. We investigated the impact of myocardial dysfunction, defined herein by a shortening fraction (SF) < 29 % at any time during or after anthracycline therapy, on late onset cardiomyopathy and all-cause mortality, among childhood cancer sur...

متن کامل

Cardiotoxicity of oncological treatment in children.

The incidence of complications after antineoplastic therapy is increasing in relation to the incidence of cancer and prolonged survival rate. Cardiotoxicity is one of the major complications, and it may occur during the therapy or many years after its termination, often leading to heart failure. Cardiotoxicity has been attributed particularly to cytostatics from the group of anthracycline antib...

متن کامل

Cardiotoxicity in childhood cancer survivors: a problem with long-term consequences in need of early detection and prevention.

I n this issue of Pediatric Blood & Cancer, Orgel et al. [1] report the prevalence of early post-treatment cardiac dysfunction in a multi-center, retrospective cohort of childhood acute myeloid leukemia (AML) survivors. After a median follow-up of 13 months from the end of treatment, patients demonstrated an 8.7% decline in left ventricular shortening fraction (LVSF) from baseline to the most r...

متن کامل

PEDIATRIC CLINICS AMSTERDAM Cardioprotective interventions for cancer patients receiving anthracyclines: a Cochrane systematic review

Anthracyclines have gained widespread use in the treatment of numerous malignancies in both adults and children. Unfortunately, their use is limited by the occurrence of cardiac damage. The precise mechanism underlying this is still not fully understood, but a major role has been ascribed to free radical generation by anthracycline-iron complexes. The heart is particularly vulnerable to free ra...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography

دوره 20 12  شماره 

صفحات  -

تاریخ انتشار 2007